Ma N - Search Results

1

Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation.

Zhao J, Zhou Y, Zhang Z, Tian F, Ma N, Liu T, Gu Z, Wang Y. Zhao J, et al. Among authors: ma n. Cancer Lett. 2010 Apr 28;290(2):238-47. doi: 10.1016/j.canlet.2009.09.013. Epub 2009 Oct 12. Cancer Lett. 2010. PMID: 19819618

2

Ultrasound-guided extrapleural Nuss procedure for pectus excavatum repair.

Zhao J, Ma N, Yuan L, Li X, Han Y. Zhao J, et al. Among authors: ma n. Ann Thorac Surg. 2014 Nov;98(5):1863-4. doi: 10.1016/j.athoracsur.2014.04.065. Epub 2014 Oct 30. Ann Thorac Surg. 2014. PMID: 25441814

3

Colobronchial fistula: the pathogenesis, clinical presentations, diagnosis and treatment.

Zhao J, Ma N, Zhao Z, Lei J, Lu Q, Tian F, Zhou Y, Han Y, Li X. Zhao J, et al. Among authors: ma n. J Thorac Dis. 2017 Jan;9(1):187-193. doi: 10.21037/jtd.2017.01.11. J Thorac Dis. 2017. PMID: 28203422 Free PMC article.

4

Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.

Huang Z, Ma N, Xiong YL, Wang L, Li WM, Lai YY, Zhang CX, Zhang ZP, Li XF, Zhao JB. Huang Z, et al. Among authors: ma n. Onco Targets Ther. 2019 Nov 27;12:10299-10309. doi: 10.2147/OTT.S210014. eCollection 2019. Onco Targets Ther. 2019. PMID: 31819514 Free PMC article.

5

Evaluation of local aggressive lung therapy versus systemic therapy in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis.

Zhang C, Ma N, Zhang Q, Zheng K, Sun C, Tang X, Li X, Zhao J. Zhang C, et al. Among authors: ma n. J Thorac Dis. 2021 Oct;13(10):5899-5910. doi: 10.21037/jtd-21-957. J Thorac Dis. 2021. PMID: 34795938 Free PMC article.

6

PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm.

Zheng KF, Liu YJ, Ma N, Xiong YL, Tang XY, Zhang Q, Luo ZL, Tian HH, Hofman P, Ichiki Y, Metro G, Tachihara M, Gong L, Li XF, Zhao JB. Zheng KF, et al. Among authors: ma n. Transl Lung Cancer Res. 2021 Dec;10(12):4617-4630. doi: 10.21037/tlcr-21-958. Transl Lung Cancer Res. 2021. PMID: 35070765 Free PMC article.

7

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.

Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG, Lv Y, Jiang T, Ma N, Zhao JB. Shi AP, et al. Among authors: ma n. Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.

8

The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes.

Tang XY, Xiong YL, Shi AP, Sun Y, Han Q, Lv Y, Shi XG, Frattini M, Malhotra J, Zheng KF, Liu YJ, Jiang T, Ma N, Zhao JB. Tang XY, et al. Among authors: ma n. Transl Lung Cancer Res. 2022 Mar;11(3):404-419. doi: 10.21037/tlcr-22-151. Transl Lung Cancer Res. 2022. PMID: 35399566 Free PMC article.

9

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Tang XY, Xiong YL, Shi XG, Zhao YB, Shi AP, Zheng KF, Liu YJ, Jiang T, Ma N, Zhao JB. Tang XY, et al. Among authors: ma n. Biomark Res. 2022 Jul 13;10(1):49. doi: 10.1186/s40364-022-00394-0. Biomark Res. 2022. PMID: 35831836 Free PMC article. Review.

10

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1-FGL1-MYH9 axis.

Tang XY, Xiong YL, Zhao YB, Yang J, Shi AP, Zheng KF, Liu YJ, Shu C, Jiang T, Ma N, Zhao JB. Tang XY, et al. Among authors: ma n. Front Immunol. 2022 Oct 4;13:1014053. doi: 10.3389/fimmu.2022.1014053. eCollection 2022. Front Immunol. 2022. PMID: 36268014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,767 results

Search Page

Filters